Crux

We’re on a mission to make transformative, FDA-approved treatments accessible and more affordable for America’s workforce. Our first step? GLP-1s for obesity management. Learn more and join the waitlist: ✨getcrux.com ✨ #GetCrux #GLP1 #Zepbound

“Employers need a better model for offering GLP-1 benefits for obesity management [to] usher in a new era of affordability, access, and better health outcomes.”👏 @RedCellPartners' @grantverstandig shares his thoughts on the GLP-1 affordability problem: wapo.st/49cPEXe

Meet @GetCruxHealth, a benefits platform for employers to offer transformative FDA-approved medications with no rebates, onerous reimbursement processes, or PBM involvement. Beginning with GLP-1 medications for obesity management, Crux allows employers of all sizes to sign up at no cost to access pass-through drug pricing and contribute non-taxed dollars to further offset employees’ out-of-pocket expenses. Crux is led by @ChipNash78, @grantverstandig, and Naimish Patel, who previously ran and expanded similar offerings at Rally Health, one of the first consumer-centric digital health companies, which was acquired by @UnitedHealthGrp in 2017. Employers can join Crux’s waitlist today to be notified when the platform launches (scheduled for early 2026): getcrux.com Cheers to the @GetCruxHealth team! 🎉 #GLP1 #GetCrux #Zepbound

Read the press release 👉 businesswire.com/news/home/2025…

At Crux, we’re giving employers new, proactive ways to cover the breakthrough therapies that employees want most, starting with GLP-1s for obesity management. Our waitlist is live, with plans to launch early in 2026. Who’s joining us? getcrux.com #GLP1 #Zepbound

Introducing Crux: the first no-fee benefit for employers to offer quality-of-life (QoL) therapies at a price that actually makes sense. Learn more and join the waitlist: ✨getcrux.com ✨ Read the press release: bwnews.pr/3MqSKOo #GetCrux